Wells Fargo’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.64K | Sell |
2,278
-33,089
| -94% | -$38.4K | ﹤0.01% | 5717 |
|
|
2025
Q1 | $56.2K | Buy |
35,367
+758
| +2% | +$1.21K | ﹤0.01% | 4910 |
|
|
2024
Q4 | $105K | Buy |
34,609
+7,305
| +27% | +$22.1K | ﹤0.01% | 4693 |
|
|
2024
Q3 | $100K | Sell |
27,304
-772
| -3% | -$2.84K | ﹤0.01% | 4627 |
|
|
2024
Q2 | $115K | Buy |
28,076
+7,995
| +40% | +$32.7K | ﹤0.01% | 4492 |
|
|
2024
Q1 | $316K | Buy |
20,081
+1,635
| +9% | +$25.8K | ﹤0.01% | 3832 |
|
|
2023
Q4 | $279K | Sell |
18,446
-31,835
| -63% | -$482K | ﹤0.01% | 3885 |
|
|
2023
Q3 | $1.01M | Sell |
50,281
-15,020
| -23% | -$301K | ﹤0.01% | 3080 |
|
|
2023
Q2 | $1.84M | Buy |
65,301
+18,544
| +40% | +$523K | ﹤0.01% | 2829 |
|
|
2023
Q1 | $804K | Buy |
46,757
+43,621
| +1,391% | +$750K | ﹤0.01% | 3312 |
|
|
2022
Q4 | $63.2K | Sell |
3,136
-2,533
| -45% | -$51K | ﹤0.01% | 4459 |
|
|
2022
Q3 | $122K | Sell |
5,669
-40,814
| -88% | -$878K | ﹤0.01% | 4218 |
|
|
2022
Q2 | $1.31M | Sell |
46,483
-81,935
| -64% | -$2.3M | ﹤0.01% | 2937 |
|
|
2022
Q1 | $5.92M | Sell |
128,418
-1,562
| -1% | -$72.1K | ﹤0.01% | 2185 |
|
|
2021
Q4 | $10.9M | Sell |
129,980
-365,751
| -74% | -$30.7M | ﹤0.01% | 1703 |
|
|
2021
Q3 | $33M | Sell |
495,731
-11,465
| -2% | -$764K | 0.01% | 1283 |
|
|
2021
Q2 | $27M | Buy |
507,196
+503,339
| +13,050% | +$26.8M | 0.01% | 1421 |
|
|
2021
Q1 | $167K | Sell |
3,857
-13,008
| -77% | -$563K | ﹤0.01% | 4919 |
|
|
2020
Q4 | $876K | Buy |
16,865
+8,415
| +100% | +$437K | ﹤0.01% | 4061 |
|
|
2020
Q3 | $276K | Buy |
8,450
+3,205
| +61% | +$105K | ﹤0.01% | 4630 |
|
|
2020
Q2 | $252K | Buy |
+5,245
| New | +$252K | ﹤0.01% | 4621 |
|